The Risk of Intracranial Hemorrhage in Japanese Patients with Acute Large Vessel Occlusion; subanalysis of the RESCUE-Japan registry

J Stroke Cerebrovasc Dis. 2016 May;25(5):1076-1080. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.022. Epub 2016 Feb 26.


Background: Recanalization therapies such as intravenous thrombolysis (IVT) or endovascular treatment (EVT) improve acute ischemic stroke outcomes; however, they carry the risk of intracranial hemorrhage (ICH). The present study assessed the frequency and predictive factor of ICH in Japanese patients with acute large vessel occlusion.

Methods: The Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-Japan Registry prospectively registered 1442 stroke patients with major vessel occlusion who were admitted to 84 Japanese stroke centers within 24 hours after onset, from July 2010 to June 2011. Among these 1442 patients, 1357 were included to evaluate the incidence rate and predictive factors of ICH within 24 hours after onset.

Results: ICH was observed in 284 (20.9%) patients. Among these patients, 46 (3.4%) had symptomatic ICH, and its incidence was higher in the recanalization therapy (IVT and/or EVT) group than in the conservative therapy group (4.5% versus 2.1%, P = .013). On multivariate analyses, symptomatic ICH was related to pretreatment antiplatelet agent use and systemic heparinization, and was related to neither IVT nor EVT.

Conclusions: Symptomatic ICH was not affected by recanalization therapy or EVT itself in Japanese patients with acute large vessel occlusion.

Keywords: Acute stroke; endovascular; intracranial hemorrhage; recanalization therapy.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / epidemiology
  • Brain Ischemia / therapy*
  • Cerebral Arterial Diseases / diagnostic imaging
  • Cerebral Arterial Diseases / epidemiology
  • Cerebral Arterial Diseases / therapy*
  • Chi-Square Distribution
  • Endovascular Procedures* / adverse effects
  • Heparin / adverse effects
  • Humans
  • Incidence
  • Intracranial Hemorrhages / chemically induced
  • Intracranial Hemorrhages / diagnostic imaging
  • Intracranial Hemorrhages / epidemiology*
  • Japan / epidemiology
  • Logistic Models
  • Multivariate Analysis
  • Odds Ratio
  • Platelet Aggregation Inhibitors / adverse effects
  • Prospective Studies
  • Registries
  • Risk Factors
  • Stroke / diagnostic imaging
  • Stroke / epidemiology
  • Stroke / therapy*
  • Thrombolytic Therapy* / adverse effects
  • Time Factors
  • Treatment Outcome


  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Heparin